Japan Generics Market Analysis

by:Green Stone     2020-07-21
Japan is the world's second largest pharmaceutical markets in the world, but due to public perception, the share of generic drugs has remained lacking in it. However, worried over rising healthcare expenses and mortality rates, the government has now been playing a vital role in promoting generics. The patent expiry of branded drugs and active ingredients will also act as a strong growth driver for current market in future. According to your findings of our latest report, the generics market in Japan stood about US$ 9 Billion completely. It estimates that the growth in generic drugs will outshine the expansion in overall pharmaceutical market. According to 'Japan Generics Market Analysis', Japan is predicted to be the next generic hub, and cancer related generics exhibit vast potential. The report finds out how vital is the role of National Health Insurance (NHI) pharmacies and Diagnosis Procedure Combination (DPC) hospitals in the industry improvements. It was observed that the DPC hospitals, in particular, have been growing at a robust rate, promoting generics insertion. We also found that ethical generics provide the majority share in the generic drugs market. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/japan-generics-market-analysis.html A detailed demographic analysis was done in the research that said that the population aged 65 years and above accounts for maximum healthcare-related expenditures in Japan, so because of this becomes the target population for generics publicity. Further, a meticulous disease and age-wise segmentation has provided the holistic understanding for this healthcare-related demand parameters prevailing in the usa. market research report The government in Japan has taken several initiatives to ensure growth and promotion of generics industry in england. Recently, special premium-based incentives have got to pharmacists on generic promotion. In near future, the government plans to usher in more reforms in medical care system. Our research talks about such revisions and reforms briefly to give a balanced outlook of the profession to individuals. Analysis of current trends, profiles of key players each morning Japanese generic market, and recent developments in which is actually a have also been included from the comprehensive inquiry. List of Figures Figure 3-1: Cancer Mortality Rate (per 100,000 Population), 2000 & 2010 Figure 5-1: Pharmaceutical Market (Billion US$), 2010-2014 Figure 5-2: Share of Generics in Pharmaceutical Market (2011) Figure 5-3: Pharmaceutical Sales by Facility (%), 2009 Figure 6-1: Healthcare Expenditure (Billion US$), 2010 & 2015 Figure 6-2: Percentage Distribution of Healthcare Expenditure by Diseases for Population Aged below 65 (2008) Figure 6-3: Percentage Distribution of Healthcare Expenditure by Diseases for Population Aged 65 and Above (2008) Figure 6-4: Share of Generic Drugs in Pharmaceuticals Market p.r.t Developed Countries (2009) Figure 6-5: Generic Drugs Market (Billion US$), 2010-2014 Figure 6-6: Market Share of Generic Drugs Manufacturers (2010) Figure 6-7: Generic Drugs Market by Segment (%), 2009 Figure 6-8: Generic Drugs Market by Medical Institution (%), 2008 & 2009 Figure 6-9: Number of DPC Hospitals (FY 2007 to FY 2010) Figure 6-10: Generic Drugs Market by Distribution Channel (%), 2008 & 2009 Figure 11-1: Sawai Pharmaceutical - Sales by Therapeutic Category (%), FY 2010 Figure 11-2: Towa Pharmaceutical - Sales by Therapeutic Category (%), Mar 2011 For more kindly visit : Japan Generics Market Analysis Or Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Fax: + 91 22 27812290 Email: info@bharatbook.com Website: http://www.bharatbook.com Follow us on twitter: http://twitter.com/#!/Sandhya3B
Custom message
Chat Online 编辑模式下无法使用
Chat Online inputting...